Correction: In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity

QR Code

Correction: In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity

Enregistré dans:

Détails bibliographiques
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/b70a7ff9ff084f94b925b3ac4b29ca26
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
par: Marie-Claude Bourgeois-Daigneault, et autres
Publié: (2021)

Experimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells.
par: Raquel Garijo, et autres
Publié: (2014)

Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis
par: Amanda W. K. AuYeung, et autres
Publié: (2021)

Structure of the vesicular stomatitis virus N⁰-P complex.
par: Cédric Leyrat, et autres
Publié: (2011)

Phase Transitions Drive the Formation of Vesicular Stomatitis Virus Replication Compartments
par: Bianca S. Heinrich, et autres
Publié: (2018)

The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSVΔ51 via aggravating endoplasmic reticulum stress
par: Jinqiong Jiang, et autres
Publié: (2021)

Vesicular Stomatitis Virus Chimeras Expressing the Oropouche Virus Glycoproteins Elicit Protective Immune Responses in Mice
par: Sarah Hulsey Stubbs, et autres
Publié: (2021)

Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
par: Sergio E. Rodriguez, et autres
Publié: (2019)

Correction: IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
Publié: (2021)

Plasma membrane phosphatidylinositol 4,5 bisphosphate is required for internalization of foot-and-mouth disease virus and vesicular stomatitis virus.
par: Angela Vázquez-Calvo, et autres
Publié: (2012)

Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression.
par: Helle Jensen, et autres
Publié: (2011)

Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.
par: Ratish Gambhira, et autres
Publié: (2014)

Intracellular Replication Inhibitory Effects of Tea Tree Oil on Vesicular Stomatitis Virus and Anti-inflammatory Activities in Vero Cells
par: Qi Shao, et autres
Publié: (2021)

Recoding of the Vesicular Stomatitis Virus L Gene by Computer-Aided Design Provides a Live, Attenuated Vaccine Candidate
par: Bingyin Wang, et autres
Publié: (2015)

Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors
par: Megan M. Slough, et autres
Publié: (2019)

IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
par: Xiaoyan Zhang, et autres
Publié: (2021)

The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
par: Kyle M. Pierce, et autres
Publié: (2021)

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
par: Zuqiang Liu, et autres
Publié: (2017)

Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.
par: Yangjin Kim, et autres
Publié: (2014)

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
par: Masmudur M. Rahman, et autres
Publié: (2021)

The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
par: Georgia Stewart, et autres
Publié: (2021)

The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
par: Xin Xie, et autres
Publié: (2022)

An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
par: Guan Wang, et autres
Publié: (2020)

New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy
par: Lundstrom K
Publié: (2018)

Author Correction: Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
par: Dae-Sun Kim, et autres
Publié: (2018)

Multi-Omics Analysis of Glioblastoma Cells’ Sensitivity to Oncolytic Viruses
par: Anastasiya V. Lipatova, et autres
Publié: (2021)

Oncolytic Virotherapy

Oncolytic Virotherapy
Publié: (2016)

The importance of curve severity, type and instrumentation strategy in the surgical correction of adolescent idiopathic scoliosis: an in silico clinical trial on 64 cases
par: Fabio Galbusera, et autres
Publié: (2021)

PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
par: Luke Russell, et autres
Publié: (2018)

Plant stomatal conductance determined transpiration and photosynthesis both contribute to the enhanced negative air ion (NAI)
par: Zhenzhen Zhang, et autres
Publié: (2021)

An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma
par: Bo Xu, et autres
Publié: (2021)

Anti-tumor activity of a miR-199-dependent oncolytic adenovirus.
par: Elisa Callegari, et autres
Publié: (2013)

A potential bat adenovirus-based oncolytic virus targeting canine cancers
par: Hiromichi Matsugo, et autres
Publié: (2021)

Oncolytic virus-derived type I interferon restricts CAR T cell therapy
par: Laura Evgin, et autres
Publié: (2020)

Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.
par: Irene Kuhn, et autres
Publié: (2008)

Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy
par: Chun-Yu Chen, et autres
Publié: (2021)

Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
par: Julia Niemann, et autres
Publié: (2019)

Co-Infection of Bovine Papular Stomatitis Virus, Rotavirus and Cryptosporidium Spp. in a Calf
par: Yesari Eroksuz, et autres
Publié: (2020)

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors
par: Amanda Rosewell Shaw, et autres
Publié: (2021)